For children, yes, the CDC’s “shared decision-making” guidance preserves the status quo in which Medicaid and U.S.

Rep. Marjorie Taylor Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine, describing the move as "Not ...

The biotech giant that soared during Operation Warp Speed now faces regulatory hurdles, political scepticism, and dwindling ...

Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

A UCLA professor of clinical obstetrics and gynecology says he still sees more bad outcomes in pregnant patients who have ...

RFK Jr.'s update removing COVID-19 vaccine recommendations for healthy children and pregnant women has raised new questions ...

Should a healthy 52-year-old woman with a normal BMI who has had Covid-19 three times and has received six previous doses of ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, ...

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

Moderna Inc. gained U.S. approval for a new COVID vaccine for a narrower group of people, in the latest sign that regulators ...

Vaccination rates across the country have continued to fall since the height of the pandemic, but the coronavirus never ...